Facilitated By

San Antonio Medical Foundation

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study investigating the Effects of Obeticholic Acid and Atorvastatin Treatment On Lipoprotein Metabolism in Subjects with Nonalcoholic Steatohepatitis

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva Foundation
Research Start Date
Status
Active

This Phase 2, double-blind, randomized, placebo-controlled, multicenter study, with an open-label LTSE, will evaluate the effect of Obeticholic Acid, and the subsequent addition of statin therapy, on lipoprotein metabolism in subjects with NASH with fibrosis stage 1 to 4, but no evidence of hepatic decompensation

Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.